Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.
Acromegaly
/ diagnosis
Adult
Age of Onset
Aged
Carpal Tunnel Syndrome
/ complications
Child, Preschool
Cross-Sectional Studies
Cubital Tunnel Syndrome
/ complications
Delayed Diagnosis
Early Diagnosis
Female
Foot
/ pathology
France
/ epidemiology
Hand
/ pathology
Humans
Hypertension
/ etiology
Male
Middle Aged
Patients
Physicians
Sex Factors
Socioeconomic Factors
Acromegaly
Diagnosis
Multiple correspondence analysis
Sign-and-symptom association
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
12
04
2018
accepted:
15
09
2018
pubmed:
1
10
2018
medline:
30
5
2019
entrez:
1
10
2018
Statut:
ppublish
Résumé
Acromegaly is characterized by a broad range of manifestations. Early diagnosis is key to treatment success, but is often delayed as symptomatology overlaps with common disorders. We investigated sign-and-symptom associations, demographics, and clinical characteristics at acromegaly diagnosis. Observational, cross-sectional, multicenter non-interventional study conducted at 25 hospital departments in France that treat acromegaly (ClinicalTrials.gov: NCT02012127). Adults diagnosed with acromegaly < 5 years were enrolled. Demographic and clinical data were obtained from medical reports and patient questionnaires. Sign-and-symptom associations were assessed by multiple correspondence analysis (MCA). Overall, 472 patients were included in the analyses. MCA was unsuccessful in identifying sign-and-symptom associations at diagnosis. Endocrinologists (29.5% patients) and other clinical specialists (37.2% patients) were commonly first to suspect acromegaly. Morphologic manifestations (83.7-87.9% patients), snoring syndrome (81.4% patients), and asthenia (79.2% patients) were frequently present at diagnosis; differences were found between sexes for specific manifestations. Rates of discrepancy between patient- and physician-reported manifestations were highest for functional signs. Earliest manifestations prior to diagnosis, according to how they were detected, were enlarged hands and feet (6.4 ± 6.8 and 6.2 ± 6.9 years, functional signs), hypertension (6.6 ± 7.5 years, complementary examination) and carpal/cubital tunnel syndrome (5.7 ± 6.7 years, functional signs with complementary examination). Results confirm the broad range of manifestations at diagnosis and delay in recognizing the disease. We identified early manifestations and sex differences that may aid physicians in diagnosing acromegaly. Discrepancy rates suggest physicians should obtain the patient's perspective and seek functional signs during diagnosis.
Identifiants
pubmed: 30269264
doi: 10.1007/s12020-018-1764-4
pii: 10.1007/s12020-018-1764-4
pmc: PMC6329724
doi:
Banques de données
ClinicalTrials.gov
['NCT02012127']
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
120-129Commentaires et corrections
Type : ErratumIn
Références
Pituitary. 1999 Jun;2(1):29-41
pubmed: 11081170
Br J Psychiatry. 1975 Mar;126:237-40
pubmed: 1125504
Can Med Assoc J. 1962 Nov 24;87:1106-9
pubmed: 13949186
J Clin Endocrinol Metab. 2003 Oct;88(10):4759-67
pubmed: 14557452
Eur J Endocrinol. 2004 Oct;151(4):439-46
pubmed: 15476442
BMJ. 2007 Oct 20;335(7624):824-5
pubmed: 17947788
J Clin Endocrinol Metab. 2008 Jan;93(1):61-7
pubmed: 17971431
J Clin Endocrinol Metab. 2008 Jun;93(6):2035-41
pubmed: 18381584
Eur J Endocrinol. 2008 Aug;159(2):89-95
pubmed: 18524797
Clin Endocrinol (Oxf). 2010 Feb;72(2):203-8
pubmed: 19473180
J Clin Epidemiol. 2010 Jun;63(6):638-46
pubmed: 19896800
Endocr J. 2010;57(6):477-83
pubmed: 20203424
Clin Chem. 2011 Apr;57(4):555-9
pubmed: 21285256
Int J Endocrinol. 2012;2012:540398
pubmed: 22518126
Patient Prefer Adherence. 2014 Jan 09;8:53-62
pubmed: 24453479
Handb Clin Neurol. 2014;124:197-219
pubmed: 25248589
PLoS One. 2015 Jun 15;10(6):e0129763
pubmed: 26075711
J Endocrinol. 2015 Aug;226(2):T141-60
pubmed: 26136383
Clin Endocrinol (Oxf). 2016 Mar;84(3):380-5
pubmed: 26433136
Pituitary. 2016 Jun;19(3):268-76
pubmed: 26742496
PLoS One. 2016 Mar 03;11(3):e0149358
pubmed: 26938983
Orphanet J Rare Dis. 2016 Oct 6;11(1):135
pubmed: 27716353
Eur J Endocrinol. 2017 May;176(5):645-655
pubmed: 28246150
Endocr Relat Cancer. 2017 Oct;24(10):505-518
pubmed: 28733467
Clin Endocrinol (Oxf). 1987 Apr;26(4):481-512
pubmed: 3308190
Acta Med Scand. 1988;223(4):327-35
pubmed: 3369313
Clin Endocrinol (Oxf). 1980 Jan;12(1):71-9
pubmed: 7379316
Medicine (Baltimore). 1994 Sep;73(5):233-40
pubmed: 7934807
Clin Endocrinol (Oxf). 1994 Jul;41(1):95-102
pubmed: 8050136